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We have shown marked promotion of both proliferation and neuronal differentiation in pluripotent P19
cells exposed to the green tea amino acid theanine, which is a good substrate for SLC38A1 responsible for
glutamine transport. In this study, we evaluated the activity of the mammalian target of rapamycin
(mTOR) kinase pathway, which participates in protein translation, cell growth and autophagy in a
manner relevant to intracellular glutamine levels, in murine neural progenitor cells exposed to theanine.
Exposure to theanine promoted the phosphorylation of mTOR and downstream proteins in neurospheres
from embryonic mouse neocortex. Although stable overexpression of SLC38A1 similarly facilitated
phosphorylation of mTOR-relevant proteins in undifferentiated P19 cells, theanine failed to additionally
accelerate the increased phosphorylation in these stable transfectants. Theanine accelerated the for-
mation of neurospheres from murine embryonic neocortex and adult hippocampus, along with facil-
itation of both 5-bromo-2’-deoxyuridine incorporation and 3-(4,5-dimethyl-2-thiazolyl)-2,5-diphenyl-
2H-tetrazolium bromide reduction in embryonic neurospheres. In embryonic neurospheres previously
exposed to theanine, a signiﬁcant increase was seen in the number of cells immunoreactive for a neu-
ronal marker protein after spontaneous differentiation. These results suggest that theanine activates the
mTOR signaling pathway for proliferation together with accelerated neurogenesis in murine un-
differentiated neural progenitor cells.
& 2015 The Authors. Published by Elsevier B.V. This is an open access article under the CC BY license
(http://creativecommons.org/licenses/by/4.0/).1. Introduction
Theanine (¼γ-glutamylethylamide) is an amino acid ingredient in
green tea with structural analogy to glutamine (Gln), which is a pre-
cursor for amino acid neurotransmitters such as γ-aminobutyric and
glutamic acids, in the brain [1]. Although an intracerebroventricular
injection of theanine protected hippocampal CA1 pyramidal neurons
from delayed neuronal death in brains of gerbils with bilateral fore-
brain global ischemia in vivo [2], theanine was a poor inhibitor of li-
gand binding to different ionotropic glutamate receptor subtypes with
high neurotoxicity in rat cortical synaptic membranes in vitro [3].
Theanine inhibited [3H]Gln incorporation without affectingr B.V. This is an open access article
oneda).[3H]glutamate uptake in rat brain synaptosomes, while both
[3H]theanine and [3H]Gln were similarly taken up in a sodium- and
structure-dependent manner [4]. Theanine intake was shown to pro-
mote the object recognition memory, along with an increase in
5-bromo-2′-deoxyuridine (BrdU) incorporation into the hippocampus,
in developing young rats [5]. Similarly, theanine prevented the cog-
nitive dysfunction in accelerated-senescence mice in vivo [6]. We have
recently shown that daily oral intake of theanine alleviated a variety of
behavioral abnormalities, in addition to preventing a transient decline
of BrdU incorporation into the hippocampal dentate gyrus, in adult
mice with traumatic severe stress [7].
In contrast, intracellular Gln was shown to participate in acti-
vation of the mammalian target of rapamycin (mTOR) kinase sig-
naling system responsible for protein translation, cell growth and
autophagy through a mechanism relevant to several membrane
transporters for Gln in cultured HeLa cells [8]. Evidence for theunder the CC BY license (http://creativecommons.org/licenses/by/4.0/).
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cellular essential amino acids is now accumulating [9]. Marked
promotion of cellular proliferation and neuronal differentiation
was seen in pluripotent P19 cells with stable overexpression of
solute carrier 38a1 (SLC38A1¼glutamine transporter, GlnT), which
is responsible for the membrane transport of Gln in the brain [10].
Theanine similarly accelerated both activities in control stable
transfectants with empty vector (EV), but failed to further facilitate
the promotion of both proliferation and neuronal differentiation
activities in stable Slc38a1 transfectants [11].
These previous ﬁndings prompted us to investigate the activity
of mTOR signaling-related molecules in neural progenitor cells
exposed to theanine. For this purpose, we employed in this study
neural progenitor cells isolated from embryonic mouse neocortex
enriched of primitive cells immunoreactive for the un-
differentiated progenitor cell marker nestin [12], in addition to the
murine embryonal carcinoma cell line P19 cells with pluripotency.
We also evaluated pharmacological actions of theanine on the
proliferation in hippocampal progenitor cells [13] isolated from
adult mice with predominant overexpression of green ﬂuorescent
protein (GFP) in cells expressing nestin [14].2. Methods
2.1. Materials
Materials used were obtained from different sources described
below. Theanine, Tokyo Kasei Kogyo (Tokyo, Japan); Pluripotent P19
stem cells derived from murine embryonal carcinoma, Riken Cell
Bank (Tsukuba, Japan); Antibodies against microtubules-associated
protein-2 (MAP2) and glial ﬁbrillary acidic protein (GFAP), 3-(4,5-
dimethyl-2-thiazolyl)-2,5-diphenyl-2H-tetrazolium bromide (MTT),
ciliary neurotrophic factor (CNTF) and all-trans retinoic acid (ATRA),
Sigma Chemicals (St. Louis, MO, USA); Antibody against BrdU, Ab-
cam (Cambridge, UK); Antibodies for phosphorylated mTOR, p70 S6
kinase (p70S6K), phosphorylated-p70S6K and phosphorylated-S6,
Cell Signaling Technology (Danvers, MA, USA); Anti-rabbit IgG an-
tibody conjugated with peroxidase and ECL™ detection reagent,
Amersham (Buckinghamshire, UK); Dulbecco’s modiﬁed Eagle
medium (DMEM), DMEM: Nutrient Mixture F-12 (DMEM/F-12) 1:1
Mixture, alpha minimal essential medium (αMEM), StemPro Accu-
tase, GlutaMAX, B27 supplement and fetal bovine serum (FBS),
GIBCO BRL (Gaithersburg, MD, USA), Epidermal growth factor (EGF)
and ﬁbroblast growth factor (FGF), Biomedical Technologies
(Stoughton, MA, USA).
2.2. Animals use
The protocol employed here meets the guideline of the Japa-
nese Society for Pharmacology and was approved by the Com-
mittee for Ethical Use of Experimental Animals at Kanazawa Uni-
versity (Permit no. 70093). All efforts were invariably made to
minimize animal suffering, to reduce the number of animals used
and to utilize alternatives to in vivo techniques.
2.3. Embryonic mouse neural progenitor cells
Neocortex was isolated from 15.5-day-old embryonic Std-ddY
mice (Japan SLC, Inc., Shizuoka, Japan), followed by trituration
through a Pasteur pipette with enzyme cocktails in phosphate-
buffered saline (PBS) and subsequent collection of the lower layer
enriched of undifferentiated progenitor cells after Percoll cen-
trifugation procedures [13,15]. Cells were cultured for 12 days
under ﬂoating conditions at 37 °C under 5% CO2 in a humidiﬁed
CO2 incubator with a half medium change every 2 days.2.4. Proliferation
Cultured neural progenitor cells were exposed to theanine for
12 days in the presence of EGF. Proliferation activity was then
quantiﬁed by MTT reduction assays [10]. Neurospheres cultured
with theanine for 8 days were incubated with 10 μM BrdU for 10 h,
followed by culture for 2 h and subsequent ﬁxation with 4% par-
aformaldehyde (PA) for the immunocytochemical detection of
BrdU [12]. Neurospheres were cultured with theanine for 6 days,
followed by further culture for 2 h and ﬁxation with 4% PA for
double staining for DNA with 10 μg/ml Hoechst33342 and 5 μg/ml
propidium iodide (PI) [12].
2.5. Differentiation
The cells were dissociated by pipetting, followed by seeding at
15,000 cells/well and subsequent culture without theanine for an
additional 6 days [10]. Cells were then subjected to im-
munocytochemistry with antibodies against MAP2 (1:500) and
GFAP (1:500) overnight at 4 °C. Quantiﬁcation was performed by
counting the number of cells immunoreactive for either MAP2 or
GFAP in a blinded fashion, followed by calculation of the individual
percentages over the number of total cells stained with
Hoechst33342 [12]. For Western blotting, cells were subjected to
sodium dodecyl sulfate polyacrylamide gel electrophoresis [11]
using antibodies against phospho-p70 S6 kinase (1:1,000), p70 S6
kinase (1:1,000), phosphor-S6 (1:1,000) and glyceraldehyde-3-
phosphate dehydrogenase (GAPDH) (1:4,000). The relative
amount of each protein was normalized by the quantitative den-
sitometric analysis using Image J software.
2.6. Stable Slc38a1 transfectants
Mouse embryonal carcinoma P19 cells were plated at a density
of 1.5105 cells/cm2, followed by culture in DMEM with 10% FBS
for 24 h and subsequent stable transfection with pSI- GlnT, pSI-GFP
and pcDNA3.1 vectors, or pSI, pSI-GFP and pcDNA3.1 vectors, using
2 mg of DNA and Lipofectamine and Plus reagent in 0.5 ml of Opti-
MEM. Cells were selected after culture in medium containing
500 mg/mL of G418 for establishment of stable transfectants with
Slc38a1 expression vector and EV in P19 cells for further studies
using clones between passages 3–6 as described previously [10].
2.7. Adult mouse neural progenitors
Hippocampus was isolated from 4-week-old Nestin-GFP trans-
genic mice, which were kindly provided by Dr. Grigori Enikolopov
(Cold Spring Harbor Laboratory, NY, USA) [14], followed by me-
chanical trituration and culture in DMEM/F12 containing 1xGlu-
taMAX, 1xB27 supplement, 20 ng/mL EGF and 20 ng/mL FGF for 14
days under ﬂoating conditions. Resultant neurospheres were dis-
sociated by StemPro Accutase, followed by culture at 300 cells/well
with theanine in DMEM/F12 containing 1xGlutaMAX, 1xB27 sup-
plement, 20 ng/mL EGF and 20 ng/mL FGF for an additional 24
days under ﬂoating conditions for the analysis of neurosphere
size. Five different visual ﬁelds were chosen at random from each
culture well under a phase contrast micrograph in a blinded
fashion, followed by calculation of the size of neurospheres com-
posed of clustered proliferating cells in parallel experiments for
summation using the Scion Image β 4.02 software as described
previously [12].
2.8. Data analysis
All results are expressed as the mean7SE, and the statistical
signiﬁcance was determined by the one-way or two-way ANOVA
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was set at po0.05.3. Results
3.1. mTOR signaling pathway
We at ﬁrst investigated the phosphorylation of several key
proteins related to the mTOR kinase pathway shown to be re-
sponsive to different amino acid signals [8,9] in undifferentiated
murine neocortical neurospheres cultured with theanine for 10
days. Theanine at 1–100 μM drastically accelerated the phos-
phorylation of both mTOR and its substrate, p70S6K, without
markedly affecting p70S6K levels (Fig. 1A). Subsequent quantiﬁ-
cation conﬁrmed statistically signiﬁcant promotion of the phos-
phorylation of mTOR, p70S6K and S6, without signiﬁcantly alter-
ing p70S6K levels, in murine neurospheres cultured with theanine
at 10–100 μM for 10 days (Fig. 1B).
3.2. Theanine in stable Slc38a1 transfectants of P19 cells
We evaluated the phosphorylation of mTOR-relevant proteins
in P19 cells stably overexpressing SLC38A1 which is capable of
transporting both Gln and theanine in the brain. Stable over-
expression of Slc38a1 did not markedly affect the endogenous le-
vel of p70S6K in the absence of theanine (Fig. 2A), but drastically
promoted the phosphorylation of p70S6K (Fig. 2B), mTOR (Fig. 2C)
and S6 (Fig. 2D). The addition of theanine led to signiﬁcant ac-
celeration of the phosphorylation of p70S6K, mTOR and S6 in aFig. 1. Effects of theanine on mTOR signaling molecules in murine neural progenitor cell
in either the presence or absence of theanine at different concentrations for 10 days, fol
mTOR signaling on Western blotting. Typical pictures are shown in the panel (A), wh
signiﬁcantly different from each control value obtained in cells not exposed to theanine.
Dunnett post hoc test.concentration-dependent manner in control cells with EV as seen
in neural progenitor cells, but failed to additionally promote the
phosphorylation of these intracellular molecules relevant to the
mTOR signaling even at the highest concentration used in stable
Slc38a1 transfectants. In stable Slc38a1 transfectants, theanine was
ineffective in affecting the endogenous level of p70S6K irrespec-
tive of the concentrations employed.
Since evidence is accumulating for involvement of the mTOR
signaling pathway in mechanisms underlying prevention of eu-
karyotic cells from undergoing autophagy [16], an attempt was
made to determine whether theanine modulates the activity of
autophagy in association with promotion of the phosphorylation
of mTOR signaling molecules in P19 cells. Western blotting ana-
lysis revealed considerably low endogenous levels of the autop-
hagy marker microtubule-associated protein-1 light chain-3
(MAP1LC3) in P19 cells, however, whereas endogenous levels of
both MAP1LC3-I and MAP1LC3-II were not markedly affected in
cells with sustained exposure to theanine at 1–100 μM for 4 days
irrespective of stable overexpression of SLC38A1 (Fig. 3).
3.3. Theanine in mouse neural progenitors
We evaluated the effects of theanine on the proliferation ac-
tivity in undifferentiated neural progenitor cells isolated from
embryonic mouse neocortex in vitro. Sustained exposure to thea-
nine led to a signiﬁcant increase in the neurosphere size during
culture for 12 days (Fig. 4A) and BrdU incorporation on Day 8
(Figs. 4B and 5), in addition to increasing MTT reducing activity on
Day 12 (Fig. 4C), in a concentration-dependent manner at a con-
centration range of 1–100 μM. However, theanine did nots. Neural progenitor cells from embryonic mouse neocortex were cultured with EGF
lowed by measurement of endogenous levels of particular proteins required for the
ile the panel (B) shows quantitative data of each protein level (n¼3). *Po0.05,
Statistical signiﬁcance was determined using the one-way ANOVA with Bonferroni/
Fig. 2. Effects of theanine on mTOR signaling molecules in stable Slc38a1 transfectants in P19 cells. Undifferentiated stable transfectants with EV or Slc38a1 were cultured
with 0.5 μM ATRA in either the presence or absence of theanine at different concentrations for 4 days, followed by measurement of endogenous levels of (A) p70S6K, (B) P-
p70S6K, (C) P-mTOR and (D) P-S6 on Western blotting. Typical gel pictures are shown in the upper lanes of each panel, while the lower columns show quantitative data of
each protein level (n¼3). *Po0.05, **Po0.01, signiﬁcantly different from each control value obtained in cells not exposed to theanine. Statistical signiﬁcance was de-
termined using the two-way ANOVA with Bonferroni/Dunnett post hoc test.
Fig. 3. Effects of theanine of MAP1LC3 levels in stable P19 transfectants. Stable
transfectants with EV or Slc38a1 were cultured with ATRA in either the presence or
absence of theanine at different concentrations for 4 days, followed by measure-
ment of endogenous levels of MAP1LC3-I and MAP1LC3-II on Western blotting. PC:
positive control, Neuro2a cells.
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Hoechst33342 as an index of cellular viability on Day 6 at con-
centrations used (Fig. 4D). To maximize the concentration-dependent pharmacological property, subsequent cellular differ-
entiation was examined in neurospheres exposed to theanine at
the highest concentration used. Prior culture with 100 μM thea-
nine signiﬁcantly increased the number of cells immunoreactive
for MAP2 with a concomitant decrease in that for GFAP, whereas
no signiﬁcant change was seen in the number of cells not im-
munoreactive for either MAP2 or GFAP (Fig. 4E).
3.4. Adult mouse hippocampal progenitors
To further elucidate pharmacological properties of theanine in
adult neurogenesis, we employed neurospheres prepared from the
hippocampus of young mice with predominant expression of GFP
in cells expressing nestin [14]. Due to limited availability of neural
progenitor cells from the hippocampus of adult Nestin-GFP trans-
genic mice, hippocampal neurospheres were formed during the
initial culture for 14 days, followed by dispersion and subsequent
further culture with theanine at concentrations of 1–100 μM for
an additional 24 days (Fig. 6A). In hippocampal sections dissected
from adult Nestin-GFP transgenic mice, GFP ﬂuorescence was de-
tected in the subgranular zone known to be enriched of neural
progenitor cells expressing nestin below the granular cell layer
stained with Hoechst33342 (Fig. 6B). Culture with 100 μM thea-
nine markedly increased the size of neurospheres formed from the
adult mouse hippocampus (Fig. 6C). Repetition of these experi-
ments revealed a signiﬁcantly increased size of adult mouse
Fig. 4. Effects of theanine on proliferation and differentiation in embryonic neural progenitors cells. Neural progenitor cells derived from embryonic mouse neocortex were
cultured with EGF in either the presence or absence of theanine at different concentrations for 4 to 12 days, followed by measurement of (A) neurosphere size (n¼5),
(B) BrdU incorporation on Day 8 (n¼3), (C) MTT reduction on Day 12 (n¼11) and (D) double staining for DNA with Hoechst33342 and PI on Day 6 (n¼3). (E) Cells were also
cultured with EGF in either the presence or absence of theanine for 12 days, followed by removal of EGF and subsequent dispersion for further culture without theanine for
an additional 6 days to induce spontaneous differentiation. The quantitative data show percentages of cells immunoreactive for either MAP2 or GFAP over the total number
of cells stained with Hoechst33342 (n¼3–5). *Po0.05, **Po0.01, signiﬁcantly different from each control value obtained in cells not exposed to theanine. Statistical
signiﬁcance was determined using the one- or two-way ANOVA with Bonferroni/Dunnett post hoc test.
Fig. 5. Neurospheres cultured for 8 days were incubated with 10 μM BrdU for 10 h,
followed by immunocytochemical detection of BrdU incorporated along with
Hoechst33342 staining.
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days (Fig. 6D).4. Discussion
The essential importance of the present ﬁndings is that the
green tea ingredient theanine, which is an amino acid with a
structural analog to Gln rather than glutamate, promoted the
phosphorylation of intracellular signaling molecules relevant to
the mTOR kinase pathway in cultured neural progenitor cells
isolated from embryonic mouse neocortex, in addition to facil-
itating both activities for proliferation and subsequent neuronal
differentiation. The abundance of neural progenitor cells in the
neocortex as well as the hippocampus is conﬁrmed in embryonic
rodent brains in our previous studies using embryonic brains of
rats [17] and mice [12]. The fact that prolonged exposure to
theanine increased the size of neurospheres obtained from the
hippocampus of adult Nestin-GFP transgenic mice gives support
for the proposal that theanine promotes proliferation for self-re-
plication in adult neurogenesis. There was a clearly high positive
correlation between the size of round neurospheres formed of
Fig. 6. Effects of theanine on neurosphere size in adult hippocampal progenitor cells. Neural progenitor cells were isolated from the hippocampus of Nestin-GFP transgenic
mice at 4 weeks old, followed by culture with both EGF and FGF for 14 days under ﬂoating conditions and subsequent dispersion for re-plating. Cells were then further
cultured for an additional 24 days in either the presence or absence of theanine at different concentrations for measurement of the size of neurospheres formed as
summarized in the panel (A). (B) Nestin-GFP transgenic mice at 4 weeks old were perfused with PA for dissection of hippocampal sections, followed by staining with
Hoechst33343 and subsequent observation of the DG under ﬂuorescence microscope. Hippocampal neurospheres from adult Nestin-GFP transgenic mice were cultured with
theanine at different concentrations. Typical ﬂuorescence pictures are shown in the panel (C), while the panel (D) shows quantitative analysis on the size of neurospheres
formed. *Po0.05, signiﬁcantly different from each control value obtained in cells not exposed to theanine. Statistical signiﬁcance was determined using the one-way ANOVA
with Bonferroni/Dunnett post hoc test.
T. Takarada et al. / Biochemistry and Biophysics Reports 5 (2016) 89–9594clustered cells and BrdU incorporation as an index of the pro-
liferation activity required for self-replication in neural progenitor
cells [12,17].
As [3H]theanine uptake was highly sensitive to the competitive
inhibition by Gln in rat brain synaptosomes and vice versa [4],
theanine seems to be a good substrate for several Gln transporters
expressed in the brain. Glutamine was required for cell prolifera-
tion in a variety of cell types such as lymphocytes, enterocytes and
tumor cells [18], while Gln facilitated proliferation through sti-
mulation of nucleotide synthesis in Caco-2 cells [19]. Although
membrane transportation of Gln was shown to regulate mTOR
kinase activity, translation and autophagy for coordination of cell
growth and proliferation [8], however, the exact mechanism by
which theanine promoted the phosphorylation of key molecules
required for mTOR signaling in place of Gln in undifferentiated
neural progenitor cells is not clariﬁed so far. Both theanine and Gln
could be similarly incorporated into the cytoplasm through par-
ticular Gln transporters expressed on cellular surface, with dif-
ferential proﬁles for activation of intracellular mTOR kinase sig-
naling processes. One possible but hitherto unproven speculation
is that theanine would be more efﬁcient than Gln in facilitating the
mTOR signaling pathway in neural progenitor cells in a particular
situation. For example, Gln but not theanine is metabolized
through glutaminolysis to produce α-ketoglutarate, which in turn
promotes the intracellular signaling mediated by mTOR kinases in
combination with the essential amino acid leucine [20]. Future
comparative pharmacological proﬁling between theanine and Gln
in undifferentiated neural progenitor cells undoubtedly gives a
clue for elucidating molecular mechanisms underlying the acti-
vation by theanine of the mTOR signaling pathway.
In contrast, mTOR signals are essential for the maintenance ofneural progenitor status in association with upregulation of sev-
eral repressor basic helix-loop-helix (bHLH) genes, such as Hes5, in
undifferentiated P19 cells [21]. Furthermore, Gln inhibited activa-
tion by arginine and leucine of the mTOR signaling in cultured rat
intestinal epithelial cells [22]. In cultured Jarkat cells, mTOR acti-
vation was only seen in the presence of an extracellular amino acid
complemented with Gln as an inevitable component [23]. In-
creased levels of intracellular Gln resulted in promotion of the
inﬂux of extracellular essential amino acids, such as leucine, in
exchange for the efﬂux of intracellular Gln, which would then
activate the mTOR signaling pathway required for protein trans-
lation, cell growth and reduced autophagy, toward facilitation of
cell growth and proliferation [8]. In stable Slc38a1 transfectant
cells, marked upregulation was seen in mRNA expression of both
activator (Mash1, Math3, NeuroD1) and repressor (Hes5) types of
transcription factors with a bHLH domain [10]. These previous
ﬁndings together with current ﬁndings, give rise to a speculative
idea that sustained exposure to theanine could stimulate the
phosphorylation mediated by mTOR signals of particular target
proteins required for the induction of bHLH genes capable of
modulating both proliferation and subsequent differentiation into
particular lineages, which occurs in an autophagy-independent
manner, in undifferentiated neural progenitor cells.Author contributions
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